Pub Date : 2024-01-01DOI: 10.33545/26649020.2024.v6.i1a.42
Ahmed Mohamed El Sayed, Aliaa Elsayed Shaban, Ehab Abd Ellatif Elgendy, Ayman Mohammed El Saeid
{"title":"Correlation between St segment elevation in the 12-lead ECG and the culprit coronary artery in patients with acute stemi undergoing primary PCI","authors":"Ahmed Mohamed El Sayed, Aliaa Elsayed Shaban, Ehab Abd Ellatif Elgendy, Ayman Mohammed El Saeid","doi":"10.33545/26649020.2024.v6.i1a.42","DOIUrl":"https://doi.org/10.33545/26649020.2024.v6.i1a.42","url":null,"abstract":"","PeriodicalId":275107,"journal":{"name":"International Journal of Cardiology Sciences","volume":"23 13","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139394254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-01DOI: 10.33545/26649020.2023.v5.i2a.29
Mohamed Sebaey Abdul-Mawla, M. El-Barbary, M. Adel, S. Badr
{"title":"Impaction of coronary artery ectasia on left ventricular systolic function by global longitudinal strain: Using two-dimensional speckle tracking echocardiography","authors":"Mohamed Sebaey Abdul-Mawla, M. El-Barbary, M. Adel, S. Badr","doi":"10.33545/26649020.2023.v5.i2a.29","DOIUrl":"https://doi.org/10.33545/26649020.2023.v5.i2a.29","url":null,"abstract":"","PeriodicalId":275107,"journal":{"name":"International Journal of Cardiology Sciences","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128144014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.33545/26649020.2023.v5.i2a.32
Dr. Rajeev Kumar Garg, S. Sathe
{"title":"Significance of ambulatory and home blood pressure monitoring in hypertension management: An Indian perspective","authors":"Dr. Rajeev Kumar Garg, S. Sathe","doi":"10.33545/26649020.2023.v5.i2a.32","DOIUrl":"https://doi.org/10.33545/26649020.2023.v5.i2a.32","url":null,"abstract":"","PeriodicalId":275107,"journal":{"name":"International Journal of Cardiology Sciences","volume":"299 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116881005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.33545/26649020.2023.v5.i1a.22
Samir Lutf, T. Al-Maimoony, A. Alarhabi
{"title":"Noninvasive predictors of coronary slow flow phenomenon in patients presenting with chronic coronary syndrome","authors":"Samir Lutf, T. Al-Maimoony, A. Alarhabi","doi":"10.33545/26649020.2023.v5.i1a.22","DOIUrl":"https://doi.org/10.33545/26649020.2023.v5.i1a.22","url":null,"abstract":"","PeriodicalId":275107,"journal":{"name":"International Journal of Cardiology Sciences","volume":"104 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132843881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.33545/26649020.2023.v5.i1a.26
R. Karnik
Hypertension is considered as a common and powerful contributor to all the major cardiovascular diseases (CVDs), including coronary disease, stroke, peripheral artery disease, renal disease, and heart failure. Results from the Framingham study indicated that high blood pressure (BP), even within what is regarded as the non-hypertensive range, imposes an increased risk of CVD. The median BP at which cardiovascular sequelae appeared in the Framingham study was 130/80 mmHg. Epidemiological data have shown that the risk of CVD rises with increasing BP levels, starting at ≥115/75 mmHg in a strong, independent, graded, and continuous manner. Early and aggressive BP lowering is mandatory as it can contribute to long-term CV risk reduction. According to the Framingham study data, 31% of strokes occur in patients with normal or high normal hypertension. Clinical trial data suggest that antihypertensive therapies, particularly those that block the renin-angiotensin-aldosterone system (RAAS), can reduce CVD risks at least partly independently of BP lowering, although a major controversy involves this question. An optimal strategy to reduce CV risk may include lifestyle modifications, promoting adherence to early and aggressive target level achievement, appropriate drug choice, and especially global risk reduction.
{"title":"Referral Pathway for Hypertension with High Cardiovascular Risk: A Review","authors":"R. Karnik","doi":"10.33545/26649020.2023.v5.i1a.26","DOIUrl":"https://doi.org/10.33545/26649020.2023.v5.i1a.26","url":null,"abstract":"Hypertension is considered as a common and powerful contributor to all the major cardiovascular diseases (CVDs), including coronary disease, stroke, peripheral artery disease, renal disease, and heart failure. Results from the Framingham study indicated that high blood pressure (BP), even within what is regarded as the non-hypertensive range, imposes an increased risk of CVD. The median BP at which cardiovascular sequelae appeared in the Framingham study was 130/80 mmHg. Epidemiological data have shown that the risk of CVD rises with increasing BP levels, starting at ≥115/75 mmHg in a strong, independent, graded, and continuous manner. Early and aggressive BP lowering is mandatory as it can contribute to long-term CV risk reduction. According to the Framingham study data, 31% of strokes occur in patients with normal or high normal hypertension. Clinical trial data suggest that antihypertensive therapies, particularly those that block the renin-angiotensin-aldosterone system (RAAS), can reduce CVD risks at least partly independently of BP lowering, although a major controversy involves this question. An optimal strategy to reduce CV risk may include lifestyle modifications, promoting adherence to early and aggressive target level achievement, appropriate drug choice, and especially global risk reduction.","PeriodicalId":275107,"journal":{"name":"International Journal of Cardiology Sciences","volume":"222 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134242504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.33545/26649020.2023.v5.i2a.31
J. Sawhney, P. Jain
In India atherosclerotic heart disease is a primary cause of mortality and morbidity. Several hypolipidemic medications target low-density lipoprotein cholesterol (LDL-C) to reduce the risk of atherosclerosis. Statins remain the gold standard for dyslipidemia management. Despite the fact that lipid-lowering medicines, particularly statins, have demonstrated significant success in lowering the risk of cardiovascular disease (CVD), many patients fail to meet the lipid targets indicated by clinical recommendations. Bempedoic acid is a novel hypolipidemic agent that inhibits the adenosine triphosphate citrate lyase enzyme in the cholesterol production pathway. Results from the Cholesterol Lowering via Bempedoic Acid [ECT1002], an ACL-Inhibiting Regimen (CLEAR) trial have demonstrated that bempedoic acid added to maximally tolerated statin therapy provided long-term safety and efficacy. Bempedoic acid is a significant addition to the therapeutic options for individuals with high LDL-C. This article explores the perspectives of Indian experts on the role of bempedoic acid in lipid management.
{"title":"Role of bempedoic acid in lipid management: An Indian perspective","authors":"J. Sawhney, P. Jain","doi":"10.33545/26649020.2023.v5.i2a.31","DOIUrl":"https://doi.org/10.33545/26649020.2023.v5.i2a.31","url":null,"abstract":"In India atherosclerotic heart disease is a primary cause of mortality and morbidity. Several hypolipidemic medications target low-density lipoprotein cholesterol (LDL-C) to reduce the risk of atherosclerosis. Statins remain the gold standard for dyslipidemia management. Despite the fact that lipid-lowering medicines, particularly statins, have demonstrated significant success in lowering the risk of cardiovascular disease (CVD), many patients fail to meet the lipid targets indicated by clinical recommendations. Bempedoic acid is a novel hypolipidemic agent that inhibits the adenosine triphosphate citrate lyase enzyme in the cholesterol production pathway. Results from the Cholesterol Lowering via Bempedoic Acid [ECT1002], an ACL-Inhibiting Regimen (CLEAR) trial have demonstrated that bempedoic acid added to maximally tolerated statin therapy provided long-term safety and efficacy. Bempedoic acid is a significant addition to the therapeutic options for individuals with high LDL-C. This article explores the perspectives of Indian experts on the role of bempedoic acid in lipid management.","PeriodicalId":275107,"journal":{"name":"International Journal of Cardiology Sciences","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114554185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.33545/26649020.2023.v5.i1a.21
Salah Yassen, Hasan AL Farhan, Zoubaida Ali Mardan Mohammed
{"title":"Relationships between clinico-biochemical markers and echo parameter including right ventricle strain with severity of pulmonary arterial hypertension (group I) in Ibn-albitar cardiac center","authors":"Salah Yassen, Hasan AL Farhan, Zoubaida Ali Mardan Mohammed","doi":"10.33545/26649020.2023.v5.i1a.21","DOIUrl":"https://doi.org/10.33545/26649020.2023.v5.i1a.21","url":null,"abstract":"","PeriodicalId":275107,"journal":{"name":"International Journal of Cardiology Sciences","volume":"335 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124714982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.33545/26649020.2023.v5.i1a.23
G. Unni, H. Baxi
{"title":"Targeting heart rate variability in heart failure: an expert opinion review on Ivabradine","authors":"G. Unni, H. Baxi","doi":"10.33545/26649020.2023.v5.i1a.23","DOIUrl":"https://doi.org/10.33545/26649020.2023.v5.i1a.23","url":null,"abstract":"","PeriodicalId":275107,"journal":{"name":"International Journal of Cardiology Sciences","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129668081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.33545/26649020.2023.v5.i1a.20
A. Shehab, Ayman Ahmed Gaafer, H. Elsokkary, S. Badr
{"title":"Association between C-Reactive protein to serum albumin ratio and thrombus load in patients with acute myocardial infarction","authors":"A. Shehab, Ayman Ahmed Gaafer, H. Elsokkary, S. Badr","doi":"10.33545/26649020.2023.v5.i1a.20","DOIUrl":"https://doi.org/10.33545/26649020.2023.v5.i1a.20","url":null,"abstract":"","PeriodicalId":275107,"journal":{"name":"International Journal of Cardiology Sciences","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126908747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.33545/26649020.2023.v5.i1a.28
Ahmed Kotb Meligy Kotb, Ayman Ahmed El-Shaikh, E. Draz, Mohamed Elsayed El-setiha
{"title":"Prediction of coronary artery disease severity from platelet to lymphocyte ratio","authors":"Ahmed Kotb Meligy Kotb, Ayman Ahmed El-Shaikh, E. Draz, Mohamed Elsayed El-setiha","doi":"10.33545/26649020.2023.v5.i1a.28","DOIUrl":"https://doi.org/10.33545/26649020.2023.v5.i1a.28","url":null,"abstract":"","PeriodicalId":275107,"journal":{"name":"International Journal of Cardiology Sciences","volume":"111 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127690354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：